Momenta Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of 2008

CAMBRIDGE, Mass., July 24, 2008 (PRIME NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced its financial results for the second quarter and six months ended June 30, 2008.

MORE ON THIS TOPIC